DDR1 and pancreatic neoplasm: We reported in an earlier study that the pharmacological inhibition of DDR1 activation by a novel small-molecule inhibitor, 7rh benzamide, inhibited tumorigenesis and enhanced chemosensitivity in orthotopic xenografts and autochthonous pancreatic tumors (12).